Research output per year
Research output per year
Fingerprint
Dive into the research topics where Uma Borate is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A blueprint for pursuing therapeutic interventions and early phase clinical trials in clonal haematopoiesis
Haque, T., Shastri, A., Desai, P., Xie, Z., Hammond, D., King, Z., Kishtagari, A., Madanat, Y. F., Abaza, Y., Silver, A. J., Singh, A., Borate, U. M., Heimlich, J. B., Slosky, D. A., Bolton, K. L., Patnaik, M. S., Bick, A. G., Verma, A. K., Jaiswal, S. & Steensma, D. P. & 1 others, , Feb 2025, In: British Journal of Haematology. 206, 2, p. 416-427 12 p.Research output: Contribution to journal › Review article › peer-review
Open Access2 Scopus citations -
Efficacy and safety of venetoclax plus azacitidine for patients with treatment-naive high-risk myelodysplastic syndromes
Garcia, J. S., Platzbecker, U., Odenike, O., Fleming, S., Fong, C. Y., Borate, U., Jacoby, M. A., Nowak, D., Baer, M. R., Peterlin, P., Chyla, B., Wang, H., Ku, G., Hoffman, D., Potluri, J. & Garcia-Manero, G., Mar 13 2025, In: Blood. 145, 11, p. 1126-1135 10 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
A study to assess the efficacy of enasidenib and risk-adapted addition of azacitidine in newly diagnosed IDH2-mutant AML
Cai, S. F., Huang, Y., Lance, J. R., Mao, H. C., Dunbar, A. J., McNulty, S. N., Druley, T., Li, Y., Baer, M. R., Stock, W., Kovacsovics, T., Blum, W. G., Schiller, G. J., Olin, R. L., Foran, J. M., Litzow, M., Lin, T., Patel, P., Foster, M. C. & Boyiadzis, M. & 18 others, , Jan 23 2024, In: Blood Advances. 8, 2, p. 429-440 12 p.Research output: Contribution to journal › Article › peer-review
Open Access9 Scopus citations -
Beat-AML 2024 ELN–refined risk stratification for older adults with newly diagnosed AML given lower-intensity therapy
Hoff, F. W., Blum, W. G., Huang, Y., Welkie, R. L., Swords, R. T., Traer, E., Stein, E. M., Lin, T. L., Archer, K., Patel, P. A., Collins, R. H., Baer, M. R., Duong, V. H., Arellano, M. L., Stock, W., Odenike, O., Redner, R. L., Kovacsovics, T., Deininger, M. W. & Zeidner, J. F. & 20 others, , Oct 22 2024, In: Blood Advances. 8, 20, p. 5297-5305 9 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/Syndromes—Recommendations From the International Consortium for Myelodysplastic Neoplasms/Syndromes (MDS [icMDS])
Aakash, F., Gisriel, S. D., Zeidan, A. M., Bennett, J. M., Bejar, R., Bewersdorf, J. P., Borate, U. M., Boultwood, J., Brunner, A. M., Buckstein, R., Carraway, H. E., Churpek, J. E., Daver, N. G., DeZern, A. E., Efficace, F., Fenaux, P., Figueroa, M. E., Garcia-Manero, G., Gore, S. D. & Greenberg, P. L. & 33 others, , Dec 2024, In: Modern Pathology. 37, 12, 100615.Research output: Contribution to journal › Review article › peer-review
1 Scopus citations